BaeYJLeblebjianHReddR, et al.The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies. J Oncol Pharm Pract2025: 10781552251397884. doi:10.1177/10781552251397884
2.
SendorRSturmerT. Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators. Pharmacoepidemiol Drug Saf2022; 31: 261–269.
3.
SuissaS. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf2007; 16: 241–249.
4.
PiaggioGElbourneDRPocockSJ, et al.Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA2012; 308: 2594–2604.
